Abstract:Target-based screening is one of the major approaches in drug discovery. Besides the intended target, unexpected drug off-target interactions often occur, and many of them have not been recognized and characterized. The off-target interactions can be responsible for either therapeutic or side effects. Thus, identifying the genome-wide off-targets of lead compounds or existing drugs will be critical for designing effective and safe drugs, and providing new opportunities for drug repurposing. Although many computational methods have been developed to predict drug-target interactions, they are either less accurate than the one that we are proposing here or computationally too intensive, thereby limiting their capability for large-scale off-target identification. In addition, the performances of most machine learning based algorithms have been mainly evaluated to predict off-target interactions in the same gene family for hundreds of chemicals. It is not clear how these algorithms perform in terms of detecting off-targets across gene families on a proteome scale. Here, we are presenting a fast and accurate off-target prediction method, REMAP, which is based on a dual regularized one-class collaborative filtering algorithm, to explore continuous chemical space, protein space, and their interactome on a large scale. When tested in a reliable, extensive, and cross-gene family benchmark, REMAP outperforms the state-of-the-art methods. Furthermore, REMAP is highly scalable. It can screen a dataset of 200 thousands chemicals against 20 thousands proteins within 2 hours. Using the reconstructed genome-wide target profile as the fingerprint of a chemical compound, we predicted that seven FDA-approved drugs can be repurposed as novel anti-cancer therapies. The anti-cancer activity of six of them is supported by experimental evidences. Thus, REMAP is a valuable addition to the existing in silico toolbox for drug target identification, drug repurposing, phenotypic screening, and side effect prediction. The software and benchmark are available at https://github.com/hansaimlim/REMAP.

PROMISCUOUS: a database for network-based drug-repositioning

Implementation of functions in R tool in parallel environment

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data

Polypharmacology Directed Compound Data Mining: Identification of Promiscuous Chemotypes with Different Activity Profiles and Comparison to Approved Drugs

Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.

Drugst.One -- A plug-and-play solution for online systems medicine and network-based drug repurposing

Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects

EK-DRD: A Comprehensive Database for Drug Repositioning Inspired by Experimental Knowledge

DrugRepoBank: a comprehensive database and discovery platform for accelerating drug repositioning

Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning

A Pathway Profile-Based Method for Drug Repositioning

DrugRepPT: a Deep Pre-Training and Fine-Tuning Framework for Drug Repositioning Based on Drug's Expression Perturbation and Treatment Effectiveness.

Design and application of a knowledge network for automatic prioritization of drug mechanisms

An Integrated Structure- and System-Based Framework to Identify New Targets of Metabolites and Known Drugs

deepDR: a network-based deep learning approach to in silico drug repositioning

PDID: Database of Molecular-Level Putative Protein-Drug Interactions in the Structural Human Proteome

Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing.

Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

Drug Repositioning Through Integration of Prior Knowledge and Projections of Drugs and Diseases

Molecular interaction networks and drug development: Novel approach to drug target identification and drug repositioning

Artificial Intelligence/Machine Learning-Driven Small Molecule Repurposing via Off-Target Prediction and Transcriptomics